Latest Headlines

1. Biomerica Signs Two Definitive Agreements With Mount Sinai Medical School In New York To Scale-Up A Laboratory Version Serological Test For COVID-19 That Enables High-Volume Screenings In Labs 4/2/2020

   Biomerica Inc. (NASDAQ: BMRA) today announced it has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine in New York to license technologies pertaining to a laboratory version serological test for SARS-CoV-2 (“COVID-19”) virus infection which have been developed at Mount Sinai

2. Bruker Highlights New Analytical Systems And Applied Market Solutions 4/1/2020

   Bruker Corporation this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research

3. MindMed Acquires Exclusive License To Eight Clinical Trials Of LSD, Partners With World-Leading Psychedelic Research Laboratory At University Hospital Basel 4/1/2020

   Mind Medicine (MindMed) Inc. (NEO: MMED OTC: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, today announced the signing of a multi-year, branch exclusive collaboration with the laboratory of Professor Dr. Matthias Liechti, the world-leading psychedelics pharmacology and clinical research group at University Hospital Basel in Switzerland

4. Boulder iQ Launches Ethylene Oxide Sterilization Service 4/1/2020

   In response to a shortage of safe, effective sterilization services used in the development of medical devices, Boulder iQ is now offering ethylene oxide (EO) sterilization services through its Boulder Sterilization division

5. BioTek Introduces New Cell Count & Viability Starter Kit 4/1/2020

   BioTek Instruments today introduced a new kit that can help researchers quickly obtain high-quality cell count results by automating the often tedious and error-prone process of mammalian cell counting

6. Our Contribution To The Supply Of Medical Care 3/31/2020

   The corona pandemic has meant an increase in demand for medical equipment, in particular ventilation and laboratory technology. With its drive systems, FAULHABER makes an important contribution in ensuring the reliable operation of equipment used in these now vital applications and is doing its utmost to safeguard supply.

7. Northwell Implements New On-Site Laboratory Treatment Technology For COVID-19 Infected Medical Waste 3/30/2020

   To minimize the risk of spreading COVID-19, Northwell Health has become the first US health system to implement a new technology that breaks down medical waste from laboratory testing in a safe, environmentally friendly way. This press release features multimedia

8. Experimental AI Tool Predicts Which Patients With Pandemic Virus Will Develop Serious Respiratory Disease 3/30/2020

   An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found

9. UC Berkeley Spin Up A Robotic COVID-19 Testing Lab 3/30/2020

   As doctors around the country scramble to diagnose cases of COVID-19, scientists at the University of California, Berkeley’s Innovative Genomics Institute (IGI) are creating from scratch a diagnostic lab with the capability to process more than 1,000 patient samples per day.

10. Biocept Enters Into Laboratory Services Agreement With Second California-Based Independent Physician Association 3/27/2020

    Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has entered into an agreement with a second California-based independent physician association (IPA) to provide its Target Selector™ liquid biopsy assay services to physicians and patients in their network